Effects of initial ischemia/reperfusion injury on the transplanted kidney

Transplantation

Volumn 64, Issue 7, 1997, Pages 945-947

  Tilney, Nicholas L ^a,b   Guttmann, Ronald D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY REACTION; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; ISCHEMIA; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; TISSUE DONORS;

EID: 0030804113     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710150-00001     Document Type: Review

References (23)

1. Terasaki PI, Yuge J, Cecka JM, et al. Thirty-year trends in clinical kidney transplantation. In: Terasaki PI, ed. Clinical Transplants 1993. Los Angeles, UCLA Tissue Typing Laboratory, 1993: 553.
2. Chertow GM, Milford EL, Mackenzie HS, et al. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA 1997; 276: 1732.
3. Terasaki PI, Cecka JH, Gertson DW, et al. High survival rates of kidney transplants from spousal and living-related donors. N Engl J Med 1995; 333: 333.
4. Kauffman M, Graham WK, Wolf JS, et al. UNOS donor data update 1988-1994. Transplant Proc 1997; 29: 122.
5. Nagareda T, Kinoshita Y, Tanaka A, et al. Clinicopathology of kidneys from brain death patients treated with vasopressin and epinephrine. Kidney Int 1993; 43: 1363.
6. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
7. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation. Transplant Rev 1996; 10: 99.
8. Menger MD, Pelikan S, Steiner D, et al. Microvascular ischemia/ reperfusion injury in striated muscle: significance of "reflow-paradox". Am J Physiol 1992; 263: 1901.
9. Kincaid-Smith P, Morris PJ, Saker BM, et al. Immediate renal graft biopsy and subsequent rejection. Lancet 1968; ii: 748.
10. Formigli C, Lombardo LD, Adembri C, et al. Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome. Human Pathol 1992; 23: 627.
11. Klausner JM, Paterson IS, Valeri CR, et al. Limb ischemia induced increase in permeability is mediated by leukocytes and leukotrienes. Ann Surg 1988; 208: 755.
12. Kelly KJ, Williams WW Jr, Colvin RB, et al. Antibody to intercellular adhesion molecule-1 protects the rat kidney against ischemic injury. Proc Natl Acad Sci USA 1994; 91: 812.
13. DeHeer E, Davidoff A, Van der Wal A, et al. Chronic renal allograft rejection in the rat: transplantation induced antibodies against basement membrane antigens. Lab Invest 1994; 70: 494.
14. Tullius SG, Tilney NL. Both antigen dependent and independent factors influence chronic allograft rejection. Transplantation 1995; 59: 3113.
15. Naimark DMJ, Cole E. Determinants of long-term renal allograft survival. Transplant Rev 1994; 3: 93.
16. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995; 59: 962.
17. Troppman C, Gillingham KJ, Gruessner RWG, et al. Delayed graft function in the absence of rejection has no long-term impact. Transplantation 1996; 61: 1331.
18. Heil J, Sutherland DER, Najarian JS, et al. Acute tubular necrosis of cadaveric renal allografts does not correlate with organ sharing or preservation time but portends a poorer prognosis for long-term graft survival. Transplant Proc 1983; 16: 270.
19. Almond PS, Matas AJ, Canafax DM. Fixed-rate reimbursement fails to cover costs for patients with delayed graft function. Pharmacotherapy 1991; 11: 126S.
20. Rosenthal JT, Danovitch GM, Wilkinson A, et al. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991; 51: 1115.
21. Pirsch JD, Pleog RJ, Grange S, et al. Determinants of graft survival after renal transplantation. Transplantation 1996; 61: 1581.
22. Terasaki PI, Koyama H, Cecka JM, et al. The hyperfiltration hypothesis in human renal transplantation. Transplantation 1994; 57: 1450.
23. Hourmant M, Bedrossian J, Durand D, et al. A randomized multi-center trial comparing LFA-1 anti-thymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996; 62: 1565.